Search results for "TLE"

showing 10 items of 2417 documents

Treatment of intrabony defects using guided tissue regeneration and autogenous spongiosa alone or combined with hydroxyapatite/beta-tricalcium phosph…

2007

The aim of this case-control study was to investigate the clinical regeneration of deep intrabony defects using guided tissue regeneration (GTR) with autogenous spongiosa (ASB) alone or using GTR with a mixture of ASB with a bovine-derived xenograft (BDX) or a synthetic composite bone substitute (hydroxyapatite/beta-tricalcium phosphate [HA/beta-TCP]).Sixty-four patients with a total of 93 intrabony defects of 2- or 3-wall morphology and an intrabony component (IC)or=4 mm participated in this study. Defects were treated with a bioabsorbable membrane and ASB alone or ASB mixed with HA/beta-TCP or BDX. Clinical parameters measured at baseline and 12 months after surgery included IC, bleeding …

AdultCalcium PhosphatesMaleBone substituteBleeding on probingTransplantation HeterologousDentistrymedicineAnimalsHumansBone regenerationPeriodontitisAgedPeriodontitisβ tricalcium phosphatebusiness.industryRegeneration (biology)SmokingAlveolar Ridge AugmentationAlveolar Ridge AugmentationMiddle Agedmedicine.diseaseTreatment efficacyBone SubstitutesGuided Tissue Regeneration PeriodontalPeriodonticsCattleFemaleHydroxyapatitesmedicine.symptombusinessEpidemiologic MethodsJournal of periodontology
researchProduct

Distribution of a special subset of keratinocytes characterized by the expression of cytokeratin 9 in adult and fetal human epidermis of various body…

1987

Biochemical analyses have previously shown that palmar and plantar epidermis, unlike the epidermis of other body sites, contain cytokeratin 9 (Mr 64,000), an unusually large acidic (type I) cytokeratin. Guinea-pig antibodies that specifically and selectively react with bovine and human cytokeratin 9 were used for the immunocytochemical identification of cytokeratin 9 in adult and fetal human epidermis from various body sites. In the epidermis of palms and soles, antibodies against cytokeratin 9 stained a high proportion of the keratinocytes in suprabasal locations. These suprabasal cytokeratin-9-positive keratinocytes were often arranged in vertical columns and concentrated around intraepid…

AdultCancer Researchmedicine.drug_classMorphogenesisFluorescent Antibody Techniquemacromolecular substancesBiologyMonoclonal antibodyBasal (phylogenetics)CytokeratinFetusmedicineAnimalsHumansMolecular BiologySkinFetusEpidermis (botany)FootCell BiologyAnatomyHandMolecular biologyCytoskeletal Proteinsmedicine.anatomical_structureEpidermal Cellsbiology.proteinKeratinsCattleAntibodyKeratinocyteNeckDevelopmental BiologyDifferentiation; research in biological diversity
researchProduct

IGF-I, IgA, and IgG responses to bovine colostrum supplementation during training.

2002

This study examined the effect of bovine colostrum (Dynamic colostrum) supplementation on blood and saliva variables ( study 1) and the absorption of orally administered human recombinant insulin-like growth factor (IGF)-I (rhIGF-I) labeled with 123I (123I-rhIGF-I) ( study 2). In study 1, adult male and female athletes were randomly assigned in a double-blind fashion to either an experimental (Dynamic; n = 19) or a control (Placebo; n = 11) group. The former consumed daily 20 g of Dynamic supplement, and the latter 20 g of maltodextrin during a 2-wk training period. After bovine colostrum supplementation, significant increases were noticed in serum IGF-I ( P < 0.01) and saliva IgA ( P &…

AdultElectrophoresisMaleSalivamedicine.medical_specialtyPhysiologyCausticsAnimal originlaw.inventionReceptor IGF Type 1Iodine RadioisotopesDouble-Blind MethodlawPhysiology (medical)Internal medicinemedicineAnimalsHumansInsulin-Like Growth Factor ITrichloroacetic AcidSalivabusiness.industryColostrumImmunoglobulin AEndocrinologyNutrition AssessmentPhysical performancePhysical FitnessImmunoglobulin GDietary SupplementsRecombinant DNAColostrumCattleFemalebusinessJournal of applied physiology (Bethesda, Md. : 1985)
researchProduct

Soccer players' fitting perception of different upper boot materials.

2016

[EN] The present study assessed the influence of upper boot materials on fitting perception. Twenty players tested three soccer boots only differing in the upper boot material (natural calf leather, natural kangaroo leather and synthetic leather). Players reported fitting perception and preference on specific foot areas using a perceived fitting scale. Ratings were averaged for every foot area. Repeated measures ANOVA was used to analyze the differences between boots. The kangaroo leather boots were perceived tighter and closer to the preferred fitting in general fitting, metatarsals area and instep area. The synthetic leather boots were perceived as the loosest and as the most distant boot…

AdultEngineeringmedia_common.quotation_subjectFootballPhysical Therapy Sports Therapy and RehabilitationHuman Factors and ErgonomicsUpperFootwear03 medical and health sciencesYoung Adult0302 clinical medicinePerceptionStatisticsSoccerAnimalsHumans0501 psychology and cognitive sciencesOperations managementSafety Risk Reliability and QualityEngineering (miscellaneous)050107 human factorsmedia_commonMacropodidaeAnalysis of Variancebusiness.industry05 social sciences030229 sport sciencesEquipment DesignConsumer BehaviorComfortShoesLeatherLeather bootsCattlePerceptionFittingbusinessApplied ergonomics
researchProduct

Fluke egg characteristics for the diagnosis of human and animal fascioliasis by Fasciola hepatica and F. gigantica

2009

In trematodiases, shape and size of the fluke eggs shed with faeces are crucial diagnostic features because of their typically reduced intraspecific variability. In fascioliasis, the usual diagnosis during the biliary stage of infection is based on the classification of eggs found in stools, duodenal contents or bile. The aim of the present study is to validate the identification of Fasciola species based on the shape and size of eggs shed by humans, characterizing their morphometric traits using a computer image analysis system (CIAS). The influence of both the geographical location and of the host (human and livestock) has been analysed. Coprological studies were carried out in fasciolias…

AdultFascioliasisPathologymedicine.medical_specialtyGeorgiaAdolescentSwineEggsVeterinary (miscellaneous)HelminthiasisZoologyParasitic disease diagnosisFecesYoung AdultHepaticaPeruparasitic diseasesImage Processing Computer-AssistedmedicineAnimalsHumansFasciola hepaticaHelminthsChildMicroscopySheepFasciolabiologyEquidaeFasciola hepaticabiology.organism_classificationmedicine.diseaseFasciolaInfectious DiseasesVietnamParasitologyInsect ScienceCattleEgyptParasitologyTrematodaActa Tropica
researchProduct

Restless legs syndrome: Epidemiological and clinicogenetic study in a South Tyrolean population isolate.

2006

Genetic contributions to restless legs syndrome (RLS) have been consistently recognized from population and family studies. To determine the clinical and genetic features of RLS in a population isolate and explore linkage to three previously described susceptibility loci on chromosomes 12q, 14q, and 9p, respectively, an isolated population in the South Tyrolean Alps was identified and 530 adults participated in the study. Using a two-step strategy, 47 patients with idiopathic RLS were ascertained. The prevalence in the population was 8.9%. Twenty-eight patients (59.6%) had at least one affected first-degree relative and were classified as hereditary cases. In a single extended pedigree, lin…

AdultGenetic MarkersMalemedicine.medical_specialtyPopulationFamily studiesLocus heterogeneityGermanyRestless Legs SyndromeSurveys and Questionnairesmental disordersEpidemiologymedicineHumansRestless legs syndromeeducationLinkage (software)Geneticseducation.field_of_studyPolymorphism Geneticbusiness.industryChromosome MappingReproducibility of Resultsmedicine.diseaseSurgeryPedigreeNeurologyItalyHomogeneousSusceptibility locusFemaleNeurology (clinical)business
researchProduct

Microdeletion 22q11 in complex cardiovascular malformations.

1997

Besides DiGeorge, velocardiofacial and conotruncal anomaly face syndromes, some of the isolated congenital heart diseases have also been associated with a chromosomal deletion in 22q11. These disease entities, which had originally been considered to have a different genetic background, are now included in the CATCH-22 microdeletion complex. CATCH 22 is an acronym for cardiac defect, abnormal facies, thymic hypoplasia or aplasia and T-cell deficiency, cleft palate, hypoparathyroidism, and hypocalcemia. In the present study, we focused on the complex cardiovascular defects (CCVD) and screened 40 patients for a microdeletion of 22q11 by fluorescence in situ hybridization using the D22S75 DNA p…

AdultHeart Defects CongenitalMalemedicine.medical_specialtyAdolescentChromosomes Human Pair 22Persistent truncus arteriosusBiologyDouble outlet right ventricleDuctus arteriosusInternal medicineConotruncal defectGeneticsmedicineHumansChildGenetics (clinical)In Situ Hybridization FluorescenceTetralogy of FallotInfant NewbornInfantAplasiamedicine.diseasemedicine.anatomical_structureEndocrinologyGreat arteriesThymic hypoplasiaChild PreschoolCardiologyFemaleChromosome DeletionHuman genetics
researchProduct

Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case-control study.

2011

Background: Kaposi's sarcoma-associated herpes virus is associated with primary effusion lymphoma and multicentric Castleman's disease. Methods: Seropositivity to lytic and latent Kaposi's sarcoma herpes virus (KSHV) antigens were examined in 2083 lymphomas and 2013 controls from six European countries. Results: Antibodies against KSHV latent and lytic antigens were detectable in 4.5% and 3.4% of controls, respectively, and 3.6% of cases (P>0.05). The KSHV seropositivity was associated with splenic marginal zone lymphoma (SMZL) (odds ratio (OR)=4.11, 95% confidence interval (CI)=1.57–10.83) and multiple myeloma (OR=0.31, 95% CI=0.11–0.85). Conclusion: The KSHV is unlikely to contribute impo…

AdultMaleCancer ResearchAdolescentvirusesShort CommunicationserologylymphomaAntibodiesSerologyhuman herpes virus 8Young AdultHerpes virusAntigenhemic and lymphatic diseasesLymphoma Primary EffusionmedicineHumansChildKaposi's sarcomaAntigens ViralSarcoma KaposiAgedAged 80 and overbiologybusiness.industryCastleman DiseaseLymphoma Non-HodgkinCase-control studyInfant Newbornvirus diseasesInfantMiddle Agedmedicine.diseaseVirologyLymphomaEuropeOncologyLytic cycleKaposi's sarcoma-associated herpes virusCase-Control StudiesChild PreschoolImmunologyHerpesvirus 8 Humanbiology.proteinFemaleepidemiologyAntibodybusinessBritish journal of cancer
researchProduct

Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lym…

2011

Pixantrone is a potentially more effective, less cardiotoxic alternative to doxorubicin for patients with aggressive non-Hodgkin lymphoma (aNHL). This phase I/II non-comparative study evaluated pixantrone in place of doxorubicin in the standard CHOP regimen (cyclophosphamide, doxorubicin, vincristine, and prednisone), i.e. CPOP (cyclophosphamide, pixantrone, vincristine, and prednisone), in patients with relapsed aNHL who had previously received CHOP ± rituximab. Patients were administered pixantrone on day 1 of each 21-day cycle. Phase I (n = 35) dose escalation from 80 mg/m(2) to 180 mg/m(2) established the phase II (n = 30) dose as 150 mg/m(2). In phase II, 20 patients (67%) received all…

AdultMaleCancer Researchmedicine.medical_specialtyVincristineCyclophosphamidePhases of clinical researchAntineoplastic AgentsPharmacologyGastroenterologychemistry.chemical_compoundPrednisoneRecurrenceInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansCyclophosphamideAgedNeoplasm StagingAged 80 and overPixantronebusiness.industryLymphoma Non-HodgkinHematologyMiddle Agedmedicine.diseaseIsoquinolinesSurvival AnalysisTreatment OutcomeOncologychemistryVincristinePrednisoneMantle cell lymphomaFemalebusinessDiffuse large B-cell lymphomaFebrile neutropeniaImmunosuppressive Agentsmedicine.drugLeukemialymphoma
researchProduct

Temsirolimus for the treatment of mantle cell lymphoma.

2010

Although recent progress has been made in the treatment of mantle cell lymphoma (MCL) the majority of patients experience relapse and ultimately die of their disease. The translocation t(11;14) is a prerequisite for the diagnosis of MCL and results in overexpression of cyclin D1. Its protein translation is controlled by mTOR, a key element of the PI3K/Akt pathway, and mTOR constitutes an attractive therapeutic target. Temsirolimus, a specific inhibitor of mTOR, has been evaluated in two Phase II trials in patients with relapsed MCL, and promising response rates up to 40% were found. Subsequently, a randomized Phase III trial was initiated, in which superiority in remission induction and pro…

AdultMaleCombination therapyChromosomal translocationAntineoplastic AgentsLymphoma Mantle-CellPharmacologyDisease-Free SurvivalDrug Administration ScheduleCyclin D1hemic and lymphatic diseasesmedicineSecondary PreventionHumansCyclin D1PI3K/AKT/mTOR pathwayAgedAged 80 and overSirolimusClinical Trials as Topicbusiness.industryTOR Serine-Threonine KinasesRemission InductionIntracellular Signaling Peptides and ProteinsHematologyMiddle Agedmedicine.diseaseTemsirolimusNon-Hodgkin's lymphomaRegimenCancer researchMantle cell lymphomaFemalebusinessmedicine.drugExpert review of hematology
researchProduct